Gliomas that come back fall into four DNA groups
Original title: Mutational signature stratification of recurrent gliomas reveals distinct patterns of genomic traits.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This only looked at DNA from tumors already removed, not at a new treatment.
The short version
Brain tumors that come back carry different DNA damage patterns, and one group stands out.
What was studied. Researchers studied 96 gliomas that came back after treatment. They compared the DNA of each returning tumor to the patient's first tumor.
What they found. The tumors sorted into four groups by the kind of DNA damage they carried. The largest group, 38 tumors, showed damage linked to the drug temozolomide: A chemotherapy taken as a capsule, used for some brain tumors. Your team checks your blood counts while you are on it. See the glossary. These tumors had many more new DNA changes than the other groups. In that group, 85% (35/41) had changes in the same three genes.
What this means, and what it doesn't
What it could mean: Doctors may be able to describe a returning tumor more clearly. The DNA pattern may show how past drug treatment shaped the tumor. It also points to genes that are worth studying next.
What it doesn't mean: This was not a test of any treatment. No one was given a new drug. The work only read DNA from tumor samples that were already removed. It does not change care today, and it is not a cure.
Source: PubMed, July 21, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.